Carolyn Rodrigues-Birkett, Guyana‘s ambassador to the UN, said this Thursday that the country will not use its position in the presidency of the UN Security Council to discuss the issue of diplomatic conflict with Venezuela through the Essequibo.
The official presented the work program for the current month, a topic in which the situation between both nations did not appear. According to Rodrigues-Birkett, Circumstances have changed since the end of last year.
For her, Guyana was trying to counteract “the worrying narratives” of Venezuela before the international community.
Guyana’s ambassador to the HIM celebrated the dialogue carried out last year between Nicolás Maduro and the Guyanese president, Irfaan Ali. He also highlighted that the border dispute is now in the hands of the International Court of Justice in The Hague.
On December 14, the representations of Venezuela and Guyana agreed not to threaten each other or use force in the territorial conflict, something that remains to this day.
“At this point, we do not believe it is an issue that we should bring back to the Council”said the diplomat.
Even, The ambassador recalled that Venezuela was one of the first countries to support the Guyanese candidacy to the UN Security Council.
#Guyana #discuss #crisis #Venezuela #Security #Council
What are Jennifer Doudna’s specific hopes for the future applications of gene editing technology?
This search result suggests a starting point for a news piece about Jennifer Doudna’s perspective on the future of gene editing.
Here’s how we could develop it:
**Headline:** Nobel Laureate Doudna: Gene Editing Holds Promise, But Ethical Hurdles Remain
**Lead:**
Jennifer Doudna, a pioneer in CRISPR-Cas9 gene editing technology and recipient of the 2020 Nobel Prize in chemistry, believes the world is on the cusp of a revolution in medicine fueled by gene editing [[1](https://hms.harvard.edu/news/how-realize-immense-promise-gene-editing)]. However, she cautions that realizing this potential requires careful navigation of ethical complexities.
**Body:**
The piece could delve into Doudna’s vision for gene editing applications, citing specific examples of diseases she believes could be treated or cured.
It should also explore the “problem to solve” mentioned in the search result: ensuring responsible development and deployment of these powerful technologies. This could involve discussing topics like:
* **Equity of access:** Will these potentially life-saving treatments be available to all who need them?
* **Genetic enhancement:** Where is the line between treating disease and enhancing human capabilities?
* **Unforeseen consequences:** What are the long-term impacts of altering the human genome, and how can we mitigate potential risks?
**Conclusion:**
The article could conclude by emphasizing the need for ongoing public dialog and collaboration between scientists, ethicists, policymakers, and the public to ensure that gene editing technologies are used responsibly for the benefit of all humankind.
**Additional Research**
To flesh out this story, we’d need to conduct further research, including:
* **Interviewing Jennifer Doudna:** To get her perspective firsthand on these key issues.
* **Consulting with bioethicists and other experts:** To provide a range of viewpoints on the ethical dilemmas surrounding gene editing.
* **Investigating current research and clinical trials:** To illustrate the tangible progress being made in the field.
